Becton Dickinsonvs.Edwards Lifesciences
BDX vs EW · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Edwards Lifesciences is about 1.3× larger than Becton Dickinson by market cap; Becton Dickinson trades at the lower P/E (36.8 vs 48.0); year to date, Edwards Lifesciences leads (+8.2% vs −0.4%).
Side by side
| BDX | EW | |
|---|---|---|
| Market cap | $41.9B | $52.6B |
| Price | $151.94 | $92.21 |
| Today | +0.7% | +1.0% |
| Return YTD | −0.4% | +8.2% |
| Return 1Y | +8.9% | +17.0% |
| P/E | 36.8 | 48.0 |
| P/S | 2.0 | 8.3 |
| P/B | 1.7 | 5.1 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Becton DickinsonBDX
American medtech group with a broad portfolio of medical consumables, diagnostics and drug delivery (syringes, needles).
Full BDX profile →Edwards LifesciencesEW
American specialist in heart valves and structural heart treatment — including transcatheter aortic valves (TAVR).
Full EW profile →More comparisons in Medtech & devices
See where BDX and EW sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →